Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Epidemiology and Infection|May 3, 2017
What happened at Vienna's Allgemeines Krankenhaus after Semmelweis's contract as Assistant in the First Maternity Division was terminated?P P Jadraque, K C CarterCurrent Pharmaceutical Design|April 19, 2016
Nanocarriers Made from Non-Ionic Surfactants or Natural Polymers for Pulmonary Drug DeliveryK C Carter, M Puig-SellartBMJ (Clinical Research Ed.)|August 19, 1989
Guidelines for medical audit: seven principlesC D Shaw, D W CostainBMJ (Clinical Research Ed.)|March 25, 1995
Health service accreditation: report of a pilot programme for community hospitalsC D Shaw, C D CollinsQuality Assurance in Health Care : the Official Journal of the International Society for Quality Assurance in Health Care|January 1, 1991
Health service accreditation in the United KingdomC D Shaw, T E BrooksAntimicrobial Agents and Chemotherapy|October 30, 2019
Genomic and Metabolomic Polymorphism among Experimentally Selected Paromomycin-Resistant Leishmania donovani StrainsC D Shaw, H Imamura, T Downing, et al.Annals of Tropical Medicine and Parasitology|June 1, 1989
Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycinK C Carter, J Alexander, A J BaillieAnnals of Tropical Medicine and Parasitology|February 1, 1992
Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconateM Collins, K C Carter, A J BaillieInternational Journal of Immunopharmacology|April 1, 1997
Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulationsR Banduwardene, A B Mullen, K C CarterThe Journal of Pharmacy and Pharmacology|September 1, 1993
Genetic control of drug-induced recovery from murine visceral leishmaniasisK C Carter, A J Baillie, J AlexanderPageof 11